Pleural Catheters Market is Anticipated to Reach US$ 53.3 Million by 2032

The global pleural catheters market reached a valuation of US$ 28.2 million in 2022 and is projected to grow at a CAGR of 6.6%, reaching US$ 53.3 million by 2032. Europe is expected to hold a 23.6% share of the global market by the end of 2032.

Pleural Catheters Market - Key Takeaways:

Leading Indication: Malignant pleural effusion remains the top indication type, capturing three-quarters of the revenue share due to its frequent use in managing both malignant and benign effusions.
Hospital Dominance: Hospitals account for two-thirds of the overall market value, driven by the availability of pleural catheters and skilled personnel for better clinical management.
Developed Markets: Developed regions hold over 60% of the market share, supported by a growing elderly population and increased access to healthcare facilities.
Asia Pacific Growth: Rising prevalence of COPD and the expansion of private hospitals in rural areas are driving the demand for pleural catheters in the Asia Pacific region.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=3128

Key Driving Factors in the Pleural Catheters Market:

Enhanced Patient Outcomes: Reduced clinical variability is crucial in driving growth within the pleural catheters market by improving patient outcomes.
Increasing Thoracic Surgeries: The rising number of thoracic surgeries is expanding the incidence of pleural diseases, thereby stimulating market growth.
Patient-Centric Benefits: Factors like reduced hospital admissions and effective symptomatic relief with minimal interventions are propelling the expansion of the pleural catheters market.

Explore the complete pleural catheters market report:
https://www.factmr.com/report/3128/pleural-catheters-market

Pleural Catheters Market - Key Restraint:

Challenges in Undeveloped Regions: Affordability and limited availability of catheter products in regions like Latin America and the Middle East & Africa are anticipated to hinder market growth in these areas.

Country-wise Insights:

The pleural catheters market in the United States was valued at US$ 10.4 million in 2022. The country benefits from a well-established healthcare sector, which positively impacts market growth. An increasing population suffering from cardiovascular diseases is expected to drive demand for pleural catheters. Additionally, factors such as easy access to healthcare facilities, robust insurance coverage, and favorable reimbursement policies contribute to the market's dominance in the U.S.

Competitive Landscape:

Key manufacturers in the pleural catheters market include Rocket Medical plc., Merit Medical Systems, Inc., Becton, Dickinson and Company, B. Braun Melsungen, and Eakin Healthcare Group. These companies are focusing on developing innovative pleural catheter products in response to the rising prevalence of chronic diseases. They are also expanding their product lines through acquisitions and integrating advanced technologies to optimize product usability.

In December 2020, Eakin Healthcare Group acquired Armstrong Medical, a firm specializing in respiratory products, to diversify its product portfolio into a new therapeutic area.

Segmentation of Pleural Catheters Industry Research

By Indication :
Malignant Pleural Effusions
Non-Malignant Recurrent Effusions
Chylothorax
Empyema
Haemothorax
By End User :
Hospitals
Ambulatory Surgical Centers
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

About the Report

This 170-page study offers readers a comprehensive market forecast of the global pleural catheters market, with historical data on demand (2014-2018) and expected projections for the period (2019-2029). The report discloses compelling insights into the demand and includes a detailed assessment of key parameters that are anticipated to exert influence during 2019 - 2029. Market statistics have been presented on the basis of indication (Malignant Pleural Effusions, Non-Malignant Recurrent Effusions, Chylothorax, Empyema, Haemothorax), and end user (hospitals and ambulatory surgical centers) across major countries of key regions.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.